Pernix Therapeutics Holdings Inc (PTX) - Financial and Strategic SWOT Analysis Review

Pernix Therapeutics Holdings Inc (PTX) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH194432FSA
  • |
  • Pages: 57
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pernix Therapeutics Holdings Inc (PTX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company's portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR) opioid agonist that is indicated for pain severe management, and long-term opioid treatment; a non-narcotic, non-addictive, and non-scheduled prescription sleep aid to treat insomnia; an antibiotic for infections of middle ear; and indications for depressive disorder in adults. Its branded and generic pharmaceuticals products span the therapeutic areas of neurology, psychiatry, and pain management. The company serves drug wholesalers, retail drug stores, and mass merchandisers. It has subsidiaries in the US and Ireland. Pernix Therapeutics is headquartered in Morristown, New Jersey, the US.

Pernix Therapeutics Holdings Inc Key Recent Developments

May 10,2018: Pernix Therapeutics Reports First Quarter 2018 Financial Results

Apr 23,2018: Pernix Therapeutics Announces Participation in Lead Bid for Acquisition of Worldwide Rights to Contrave for Weight Loss

Mar 08,2018: Pernix Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

Feb 06,2018: Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion

Nov 16,2017: Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Pernix Therapeutics Holdings Inc-Key Facts 6

Pernix Therapeutics Holdings Inc-Key Employees 7

Pernix Therapeutics Holdings Inc-Key Employee Biographies 8

Pernix Therapeutics Holdings Inc-Major Products and Services 9

Pernix Therapeutics Holdings Inc-History 10

Pernix Therapeutics Holdings Inc-Company Statement 11

Pernix Therapeutics Holdings Inc-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Company Overview 15

Pernix Therapeutics Holdings Inc-Business Description 16

R&D Overview 16

Pernix Therapeutics Holdings Inc-SWOT Analysis 17

SWOT Analysis-Overview 17

Pernix Therapeutics Holdings Inc-Strengths 17

Pernix Therapeutics Holdings Inc-Weaknesses 18

Pernix Therapeutics Holdings Inc-Opportunities 19

Pernix Therapeutics Holdings Inc-Threats 20

Pernix Therapeutics Holdings Inc-Key Competitors 21

Section 3-Company Financial Ratios 22

Financial Ratios-Capital Market Ratios 22

Financial Ratios-Annual Ratios 23

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Pernix Therapeutics Holdings Inc, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

May 10, 2018: Pernix Therapeutics Reports First Quarter 2018 Financial Results 32

Mar 08, 2018: Pernix Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results 33

Feb 06, 2018: Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion 36

Nov 16, 2017: Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors 37

Nov 07, 2017: Pernix Therapeutics Reports Third Quarter 2017 Financial Results 38

Oct 17, 2017: Pernix Therapeutics Announces Planned Departure of Chief Financial Officer 41

Jul 27, 2017: Pernix Therapeutics Reports Second Quarter 2017 Financial Results and Provides Business Update 42

Jul 20, 2017: Pernix Therapeutics Pre-Announces Certain Preliminary Second Quarter 2017 Financial Results 45

May 15, 2017: Pernix Therapeutics Reports First Quarter 2017 Financial Results and Provides Business Update 47

Mar 28, 2017: Pernix Therapeutics Announces Fourth Quarter And Full Year 2016 Financial Results 49

Section 6-Appendix 53

Methodology 53

Ratio Definitions 53

About GlobalData 57

Contact Us 57

Disclaimer 57

List of Figures

Pernix Therapeutics Holdings Inc, Performance Chart (2013-2017) 26

Pernix Therapeutics Holdings Inc, Ratio Charts 28

Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

List of Tables

Pernix Therapeutics Holdings Inc, Key Facts 6

Pernix Therapeutics Holdings Inc, Key Employees 7

Pernix Therapeutics Holdings Inc, Key Employee Biographies 8

Pernix Therapeutics Holdings Inc, Major Products and Services 9

Pernix Therapeutics Holdings Inc, History 10

Pernix Therapeutics Holdings Inc, Subsidiaries 14

Pernix Therapeutics Holdings Inc, Key Competitors 21

Pernix Therapeutics Holdings Inc, Ratios based on current share price 22

Pernix Therapeutics Holdings Inc, Annual Ratios 23

Pernix Therapeutics Holdings Inc, Annual Ratios (Cont...1) 24

Pernix Therapeutics Holdings Inc, Annual Ratios (Cont...2) 25

Pernix Therapeutics Holdings Inc, Interim Ratios 27

Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Pernix Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Pernix Therapeutics Holdings Inc, Recent Deals Summary 31

Currency Codes 53

Capital Market Ratios 53

Equity Ratios 54

Profitability Ratios 54

Cost Ratios 55

Liquidity Ratios 55

Leverage Ratios 56

Efficiency Ratios 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Vanda Pharmaceuticals Inc

Pfizer Inc

Adamis Pharmaceuticals Corp

Pernix Therapeutics Holdings Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8918
Site License
USD 250 INR 17835
Corporate User License
USD 375 INR 26753

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com